Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...

There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...

This decision maintains Bausch's patent rights for treating hepatic encephalopathy, impacting the U.S. pharmaceutical ...

Lipocine (LPCN) announced the publication and discussion of a manuscript “Oral LPCN 1148 Improves Sarcopenia and Hepatic Encephalopathy in Male ...

Companiesannounced the first look at its late-stage RED-C clinical trial program which will be presented at the American ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

This clinical program was designed to assess the efficacy of a next generation therapeutic, a soluble solid dispersion (SSD) immediate-release rifaximin product, to delay onset of first overt hepatic ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the publication and ...

Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent overt ...

A new study published in the Journal of Family Medicine and Primary Care found that higher degrees of hepatic encephalopathy ...

This medication is an antibiotic, prescribed for traveler's diarrhea caused by certain bacteria and liver disease affecting the brain (hepatic encephalopathy). It prevents the growth of bacteria ...

A recent study highlights the importance of zinc in patients with severe liver disease, especially those suffering from a brain-related complication called hepatic encephalopathy (HE). Conducted at ...